- Home
- ZJYL vs PEPG Comparison
ZJYL vs PEPG Comparison
Compare ZJYL & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZJYL
- PEPG
- Stock Information
- Founded
- ZJYL 2006
- PEPG 2018
- Country
- ZJYL China
- PEPG United States
- Employees
- ZJYL N/A
- PEPG N/A
- Industry
- ZJYL Industrial Specialties
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- ZJYL Consumer Discretionary
- PEPG Health Care
- Exchange
- ZJYL Nasdaq
- PEPG Nasdaq
- Market Cap
- ZJYL 142.5M
- PEPG 118.3M
- IPO Year
- ZJYL 2023
- PEPG 2022
- Fundamental
- Price
- ZJYL $1.04
- PEPG $2.72
- Analyst Decision
- ZJYL
- PEPG Buy
- Analyst Count
- ZJYL 0
- PEPG 3
- Target Price
- ZJYL N/A
- PEPG $14.67
- AVG Volume (30 Days)
- ZJYL 555.3K
- PEPG 270.5K
- Earning Date
- ZJYL 07-26-2024
- PEPG 03-05-2025
- Dividend Yield
- ZJYL N/A
- PEPG N/A
- EPS Growth
- ZJYL N/A
- PEPG N/A
- EPS
- ZJYL 0.02
- PEPG N/A
- Revenue
- ZJYL $20,125,185.00
- PEPG N/A
- Revenue This Year
- ZJYL N/A
- PEPG N/A
- Revenue Next Year
- ZJYL N/A
- PEPG N/A
- P/E Ratio
- ZJYL $48.77
- PEPG N/A
- Revenue Growth
- ZJYL 0.75
- PEPG N/A
- 52 Week Low
- ZJYL $0.70
- PEPG $2.67
- 52 Week High
- ZJYL $16.60
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- ZJYL 53.24
- PEPG 23.94
- Support Level
- ZJYL $0.76
- PEPG $3.69
- Resistance Level
- ZJYL $1.08
- PEPG $4.48
- Average True Range (ATR)
- ZJYL 0.19
- PEPG 0.33
- MACD
- ZJYL 0.03
- PEPG -0.06
- Stochastic Oscillator
- ZJYL 42.34
- PEPG 2.77
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is primarily engaged in the design, development, manufacturing, and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's products are sold to distributors in both China and in overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, nursing products, and conlo products.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.